Sequenom (SQNM -1%) bounces back after saying the USPTO has withdrawn the patent on the...

|By:, SA News Editor

Sequenom (SQNM -1%) bounces back after saying the USPTO has withdrawn the patent on the company's Diagnosing Fetal Chromosomal Aneuploidy Using Massively Parallel Genomic Sequencing. The agency said it was withdrawn in connection with an anticipated patent interference proceeding between parties with pending patent applications or issued patents directed to similar subject matter.